Siga Technologies INC Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense
Siga Technologies INC (SIGA) reported Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense of $431.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Expense Statement
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense · last filed 2026-03-10
- Siga Technologies INC unrecognized tax benefits, income tax penalties and interest expense for fiscal 2025 was $431.00K.
- Siga Technologies INC unrecognized tax benefits, income tax penalties and interest expense for fiscal 2024 was -$101.00K.
- Siga Technologies INC unrecognized tax benefits, income tax penalties and interest expense for fiscal 2023 was -$142.00K.
- Siga Technologies INC unrecognized tax benefits, income tax penalties and interest expense for fiscal 2022 was -$23.00K, a 176.67% decline from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 12 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 12 month as first filed |
|---|---|---|
| 2025-12-31 | $431.00K 10-K · filed 2026-03-10 | |
| 2024-12-31 | -$101.00K 10-K · filed 2026-03-10 | |
| 2023-12-31 | -$142.00K 10-K · filed 2025-03-11 | $142.00K 10-K · filed 2024-03-12 |
| 2022-12-31 | -$23.00K 10-K · filed 2024-03-12 | $23.00K 10-K · filed 2023-03-02 |
| 2021-12-31 | $30.00K 10-K · filed 2023-03-02 | $95.00K 10-K · filed 2022-03-03 |
| 2020-12-31 | $65.00K 10-K · filed 2022-03-03 | |
| 2019-12-31 | $38.00K 10-K · filed 2021-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |